Home › Niet-kleincellige longkanker › Arizona › Gilbert
Niet-kleincellige longkanker klinische studies in Gilbert, AZ
12 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Gilbert (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RekruterenFase 3
- Banner MD Anderson Cancer Center ( Site 0181), Gilbert
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekruterenFase 1
- Research Site, Gilbert
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruterenFase 3
- Ironwood Cancer & Research Centers, Gilbert
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruterenObservatieonderzoek
- Banner Health, Gilbert
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RekruterenFase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekruterenFase 1/2
- Banner Health- MD Anderson Cancer Center, Gilbert
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruterenFase 3
- Banner MD Anderson Cancer Center, Gilbert
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekruterenFase 3
- Research Site, Gilbert
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekruterenFase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RekruterenFase 2
- Banner Health MD Anderson, Gilbert
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruterenFase 1/2
- Banner Health, Gilbert
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekruterenFase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Andere studies in Gilbert
- Colorectale kanker9 studies
- Borstkanker9 studies
- Longkanker8 studies
- Kanker (alle vormen)8 studies
- Plaveiselcelcarcinoom van hoofd en hals6 studies
- Metastatische kanker6 studies
- Multipel myeloom6 studies
- Hartfalen6 studies
- Cardiovasculaire ziekte6 studies
- Blasenkanker6 studies
- Non-Hodgkinlymfoom5 studies
- Diffuse groot-B-cel lymfoom5 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.